Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

CT assessment of tumor heterogeneity and the potential for the prediction of human papillomavirus status in oropharyngeal squamous cell carcinoma.

Mungai F, Verrone GB, Pietragalla M, Berti V, Addeo G, Desideri I, Bonasera L, Miele V.

Radiol Med. 2019 Mar 25. doi: 10.1007/s11547-019-01028-6. [Epub ahead of print]

PMID:
30911988
2.

Primary Progressive Aphasia: Natural History in an Italian Cohort.

Ferrari C, Polito C, Vannucchi S, Piaceri I, Bagnoli S, Lombardi G, Lucidi G, Berti V, Nacmias B, Sorbi S.

Alzheimer Dis Assoc Disord. 2019 Jan-Mar;33(1):42-46. doi: 10.1097/WAD.0000000000000282.

PMID:
30640256
3.

Characterization of functionally significant coronary artery disease by a coronary computed tomography angiography-based index: a comparison with positron emission tomography.

Anagnostopoulos CD, Siogkas PK, Liga R, Benetos G, Maaniitty T, Sakellarios AI, Koutagiar I, Karakitsios I, Papafaklis MI, Berti V, Sciagrà R, Scholte AJHA, Michalis LK, Gaemperli O, Kaufmann PA, Pelosi G, Parodi O, Knuuti J, Fotiadis DI, Neglia D.

Eur Heart J Cardiovasc Imaging. 2019 Aug 1;20(8):897-905. doi: 10.1093/ehjci/jey199.

PMID:
30629151
4.

Contribution of Bilingualism to Cognitive Reserve of an Italian Literature Professor at High Risk for Alzheimer's Disease.

Lombardi G, Polito C, Berti V, Bagnoli S, Nacmias B, Pupi A, Sorbi S.

J Alzheimers Dis. 2018;66(4):1389-1395. doi: 10.3233/JAD-180736.

PMID:
30475769
5.

Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation.

Bessi V, Piaceri I, Padiglioni S, Bagnoli S, Berti V, Sorbi S, Nacmias B.

J Neurol Sci. 2018 Sep 15;392:34-37. doi: 10.1016/j.jns.2018.06.026. Epub 2018 Jun 30. No abstract available.

PMID:
30097151
6.

The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas.

Rigacci L, Kovalchuk S, Berti V, Puccini B, Mannelli L, Benelli G, Dini C, Pupi A, Bosi A.

World J Nucl Med. 2018 Jul-Sep;17(3):157-165. doi: 10.4103/wjnm.WJNM_42_17.

7.

Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.

Berti V, Walters M, Sterling J, Quinn CG, Logue M, Andrews R, Matthews DC, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Mosconi L.

Neurology. 2018 May 15;90(20):e1789-e1798. doi: 10.1212/WNL.0000000000005527. Epub 2018 Apr 13.

8.

Biomarkers study in atypical dementia: proof of a diagnostic work-up.

Lombardi G, Polito C, Berti V, Ferrari C, Lucidi G, Bagnoli S, Piaceri I, Nacmias B, Pupi A, Sorbi S.

Neurol Sci. 2018 Jul;39(7):1203-1210. doi: 10.1007/s10072-018-3400-8. Epub 2018 Apr 13.

PMID:
29651720
9.

Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.

Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Swerdlow RH, Diaz Brinton R.

PLoS One. 2018 Feb 15;13(2):e0193314. doi: 10.1371/journal.pone.0193314. eCollection 2018.

10.

Diffusion-Weighted and Perfusion-Weighted MRI to Evaluate Therapeutic Response in Lymphoma: A Comparison with FDG-PET/CT.

Calistri L, Puccini B, Berti V, Grazzini G, Nardi C, Rigacci L, Colagrande S.

Acta Haematol. 2018;139(2):74-76. doi: 10.1159/000485548. Epub 2018 Jan 26. No abstract available.

PMID:
29393082
11.

Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.

Ferrari C, Lombardi G, Polito C, Lucidi G, Bagnoli S, Piaceri I, Nacmias B, Berti V, Rizzuto D, Fratiglioni L, Sorbi S.

J Alzheimers Dis. 2018;61(2):785-791. doi: 10.3233/JAD-170665.

PMID:
29226870
12.

Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline.

Piaceri I, Bessi V, Matà S, Polito C, Tedde A, Berti V, Bagnoli S, Braccia A, Del Mastio M, Pignone AM, Pupi A, Sorbi S, Nacmias B.

J Alzheimers Dis. 2018;61(1):41-46. doi: 10.3233/JAD-170694.

PMID:
29103041
13.

Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.

Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Swerdlow RH, Brinton RD.

PLoS One. 2017 Oct 10;12(10):e0185926. doi: 10.1371/journal.pone.0185926. eCollection 2017. Erratum in: PLoS One. 2018 Feb 15;13(2):e0193314.

14.

Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.

Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Brinton RD.

Neurology. 2017 Sep 26;89(13):1382-1390. doi: 10.1212/WNL.0000000000004425. Epub 2017 Aug 30.

15.

Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.

Lombardi G, Berti V, Tedde A, Bagnoli S, Piaceri I, Polito C, Lucidi G, Ferrari C, Ginestroni A, Moretti M, Pupi A, Nacmias B, Sorbi S.

J Alzheimers Dis. 2017;57(3):697-703. doi: 10.3233/JAD-161170.

PMID:
28304299
16.

Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.

Castagnoli H, Ferrantini C, Coppini R, Passeri A, Baldini K, Berti V, Cecchi F, Olivotto I, Sciagrà R.

Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2413-2422. Epub 2016 Aug 16.

PMID:
27527796
17.

The Burden of Rheumatic Diseases: An Analysis of an Italian Administrative Database.

Iannazzo S, Furneri G, Demma F, Distante C, Parisi S, Berti V, Fusaro E.

Rheumatol Ther. 2016 Jun;3(1):167-177. doi: 10.1007/s40744-016-0034-2. Epub 2016 May 26.

18.

Cerebral metabolic rate of glucose quantification with the aortic image-derived input function and Patlak method: numerical and patient data evaluation.

Vanzi E, Berti V, Polito C, Freddi I, Comis G, Rubello D, Sorbi S, Pupi A.

Nucl Med Commun. 2016 Aug;37(8):849-59. doi: 10.1097/MNM.0000000000000512.

PMID:
27058363
19.

Segmental quantitative myocardial perfusion with PET for the detection of significant coronary artery disease in patients with stable angina.

Berti V, Sciagrà R, Neglia D, Pietilä M, Scholte AJ, Nekolla S, Rouzet F, Pupi A, Knuuti J.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1522-9. doi: 10.1007/s00259-016-3362-0. Epub 2016 Mar 18.

PMID:
26993310
20.

Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.

Berti V, Polito C, Lombardi G, Ferrari C, Sorbi S, Pupi A.

Neurol Sci. 2016 May;37(5):663-72. doi: 10.1007/s10072-016-2477-1. Epub 2016 Jan 20. Review.

PMID:
26792010
21.

Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals.

Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, Williams S, Pirraglia E, Vallabhajosula S, McHugh P, Pupi A, de Leon MJ, Mosconi L.

J Nutr Health Aging. 2015 Apr;19(4):413-23. doi: 10.1007/s12603-014-0534-0.

22.

Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review.

Sorbi F, Prosperi P, Villanucci A, Berti V, Sisti G, Fambrini M.

Gynecol Obstet Invest. 2015;80(4):265-71. doi: 10.1159/000366476. Epub 2015 Feb 10.

PMID:
25677585
23.

Human striatum remodelling after neurotransplantation in Huntington's disease.

Gallina P, Paganini M, Biggeri A, Marini M, Romoli A, Sarchielli E, Berti V, Ghelli E, Guido C, Lombardini L, Mazzanti B, Simonelli P, Peri A, Maggi M, Porfirio B, Di Lorenzo N, Vannelli GB.

Stereotact Funct Neurosurg. 2014;92(4):211-7. doi: 10.1159/000360583. Epub 2014 Jul 30.

PMID:
25096235
24.
25.

Fetal striatal grafting slows motor and cognitive decline of Huntington's disease.

Paganini M, Biggeri A, Romoli AM, Mechi C, Ghelli E, Berti V, Pradella S, Bucciantini S, Catelan D, Saccardi R, Lombardini L, Mascalchi M, Massacesi L, Porfirio B, Di Lorenzo N, Vannelli GB, Gallina P.

J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):974-81. doi: 10.1136/jnnp-2013-306533. Epub 2013 Dec 17.

26.

Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease.

Tomberli B, Cecchi F, Sciagrà R, Berti V, Lisi F, Torricelli F, Morrone A, Castelli G, Yacoub MH, Olivotto I.

Eur J Heart Fail. 2013 Dec;15(12):1363-73. doi: 10.1093/eurjhf/hft104. Epub 2013 Jun 30.

27.

Bile leak after elective laparoscopic cholecystectomy: role of MR imaging.

Mungai F, Berti V, Colagrande S.

J Radiol Case Rep. 2013 Jan;7(1):25-32. doi: 10.3941/jrcr.v7i1.1261. Epub 2013 Jan 1.

28.

Detection of infarct size safety threshold for left ventricular ejection fraction impairment in acute myocardial infarction successfully treated with primary percutaneous coronary intervention.

Sciagrà R, Cipollini F, Berti V, Migliorini A, Antoniucci D, Pupi A.

Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):542-7. doi: 10.1007/s00259-012-2329-z. Epub 2013 Jan 10.

PMID:
23306808
29.

[Aspirin in primary prevention of cardiovascular diseases: how to balance risks and benefits].

De Caterina R, Orlando D, Berti V, Coccheri S.

G Ital Cardiol (Rome). 2012 Jul-Aug;13(7-8):494-502. doi: 10.1714/1114.12245. Review. Italian.

PMID:
22781376
30.

Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease.

Berti V, Polito C, Borghammer P, Ramat S, Mosconi L, Vanzi E, De Cristofaro MT, De Leon M, Sorbi S, Pupi A.

Q J Nucl Med Mol Imaging. 2012 Jun;56(3):299-308.

31.

PET/CT in diagnosis of movement disorders.

Berti V, Pupi A, Mosconi L.

Ann N Y Acad Sci. 2011 Jun;1228:93-108. doi: 10.1111/j.1749-6632.2011.06025.x. Review.

32.

PET/CT in diagnosis of dementia.

Berti V, Pupi A, Mosconi L.

Ann N Y Acad Sci. 2011 Jun;1228:81-92. doi: 10.1111/j.1749-6632.2011.06015.x. Review.

33.

Alzheimer's disease: genetic basis and amyloid imaging as endophenotype.

Berti V, Nacmias B, Bagnoli S, Sorbi S.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):225-36. Review.

PMID:
21532537
34.

Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction.

Berti V, Sciagrà R, Acampa W, Ricci F, Cerisano G, Gallicchio R, Vigorito C, Pupi A, Cuocolo A.

Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1124-31. doi: 10.1007/s00259-011-1739-7. Epub 2011 Feb 15.

PMID:
21327635
35.

Structural brain changes in normal individuals with a maternal history of Alzheimer's.

Berti V, Mosconi L, Glodzik L, Li Y, Murray J, De Santi S, Pupi A, Tsui W, De Leon MJ.

Neurobiol Aging. 2011 Dec;32(12):2325.e17-26. doi: 10.1016/j.neurobiolaging.2011.01.001. Epub 2011 Feb 12.

36.

Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.

von zur Muhlen C, Fink-Petri A, Salaklang J, Paul D, Neudorfer I, Berti V, Merkle A, Peter K, Bode C, von Elverfeldt D.

Contrast Media Mol Imaging. 2010 Sep-Oct;5(5):268-75. doi: 10.1002/cmmi.384.

PMID:
20973112
37.

Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease.

Polito C, Berti V, Ramat S, Vanzi E, De Cristofaro MT, Pellicanò G, Mungai F, Marini P, Formiconi AR, Sorbi S, Pupi A.

Neurobiol Aging. 2012 Jan;33(1):206.e29-39. doi: 10.1016/j.neurobiolaging.2010.09.004. Epub 2010 Oct 20.

PMID:
20961661
38.

Reliability of myocardial perfusion gated SPECT for the reproducible evaluation of resting left ventricular functional parameters in long-term follow-up.

Sciagrà R, Berti V, Genovese S, Pupi A.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1722-9. doi: 10.1007/s00259-010-1444-y.

PMID:
20393711
39.

Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes.

Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, de Leon M.

Hum Genomics. 2010 Feb;4(3):170-93. Review.

40.

Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.

Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S, Glodzik L, De Santi S, Vallabhajosula S, de Leon MJ.

Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5949-54. doi: 10.1073/pnas.0914141107. Epub 2010 Mar 15.

41.

Early detection of Alzheimer's disease with PET imaging.

Berti V, Osorio RS, Mosconi L, Li Y, De Santi S, de Leon MJ.

Neurodegener Dis. 2010;7(1-3):131-5. doi: 10.1159/000289222. Epub 2010 Mar 3. Review.

42.

Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging.

Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, de Leon MJ.

J Alzheimers Dis. 2010;20(3):843-54. doi: 10.3233/JAD-2010-091504. Review.

43.

Evaluation of Early Dementia (Mild Cognitive Impairment).

Osorio RS, Berti V, Mosconi L, Li Y, Glodzik L, De Santi S, de Leon MJ.

PET Clin. 2010 Jan;5(1):15-31. doi: 10.1016/j.cpet.2009.12.003. Epub 2010 May 27. Review.

PMID:
27157481
44.

Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease.

Berti V, Polito C, Ramat S, Vanzi E, De Cristofaro MT, Pellicanò G, Mungai F, Marini P, Formiconi AR, Sorbi S, Pupi A.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):537-44. doi: 10.1007/s00259-009-1259-x. Epub 2009 Sep 2.

PMID:
19727712
45.

Clinical correlation of the binding potential with 123I-FP-CIT in de novo idiopathic Parkinson's disease patients.

Berti V, Pupi A, Ramat S, Vanzi E, De Cristofaro MT, Pellicanò G, Mungai F, Marini P, Sorbi S.

Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2220-6. doi: 10.1007/s00259-008-0872-4. Epub 2008 Jul 23.

PMID:
18649079
46.

[Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].

Boero R, Prodi E, Borsa S, Berti V, Fiorio E, Ferraro L, Massara C, Quarello F.

G Ital Nefrol. 2002 Jul-Aug;19(4):413-8. Italian.

PMID:
12369043

Supplemental Content

Support Center